Clinical Trials List
2017-08-10 - 2021-06-30
Phase III
Terminated12
ICD-10D00.1
Carcinoma in situ of esophagus
ICD-10C15
Malignant neoplasm of esophagus
ICD-9230.1
Carcinoma in situ of esophagus
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- JHE-CYUAN GUO Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 劉奕廷 Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- 陳炳憲 Division of General Surgery
- 謝致政 Division of General Surgery
- Muh-Hwa Yang Division of Hematology & Oncology
- 黃建勝 Division of General Surgery
- 陳盛裕 未分科
- Yi-Ping Hung Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Yu-Chung Wu Division of General Surgery
- 吳美翰 Division of General Surgery
- Chueh-Chuan Yen Division of Hematology & Oncology
- 徐博奎 Division of General Surgery
- Sheng-Yu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
11 Completed
Audit
None
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 黃泰霖 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- 湯禹舜 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 林偉哲 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Wang Yao-Kuang Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- Ta-Chih Liu Division of Hematology & Oncology
- Fang-Jung Yu Yu Division of Hematology & Oncology
- 蔡郁棻 Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 蘇裕傑 Division of Hematology & Oncology
- 楊文祺 Division of Hematology & Oncology
- Sheng-Fung Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- Hsien-Kun Chang Division of Hematology & Oncology
- Mengting Peng Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Chi-Ju Yeh Division of Hematology & Oncology
- 張献崑 Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- 張鈞弼 無
- Wen-Cheng Chang Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
6 Completed
Audit
CRO
Co-Principal Investigator
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
939 participants
